By completing your purchase, you acknowledge that SLU-PP-332 is an investigational material not approved for general medical or therapeutic use by any regulatory authority
There is no official link between these compounds and specific adverse event reports in the UK at this time, but the absence of reported harm does not confirm safety
This product is formulated at the 0.9% (9 mg/mL) USP standard benzyl alcohol concentration
Recommended screening items: list of SNPs to consider MTHFR C677T/A1298C, FTO rs9939609, MC4R variants, FSHR polymorphisms, CYP19A1, ESR1/2, INS/IRS1, APOE alleles, and variants affecting thyroid hormone conversion (DIO2)
Certificate of analysis (CoA) for the specific batch Documents potency, purity, and sterility testing results